Great interview with CEO Gary Rabin on Seeking Alpha today.
Gary was saying they are talking with China about partnering, I hope not, China will screw ACTC. A partnership with anyone but China would be great.
Advanced Cell Technology (ACTC.OB) is
a biotechnology company focused on the development and commercialization of
human embryonic and adult stem cell technology in the field of regenerative
medicine. Their main focus revolves around macular degeneration, which is an
unmet medical need for the world worth well over $30 billion. ACTC has treated
nine patients between their three ongoing trials. All of the patients are
reported as doing remarkably well, and there have been no safety issues
whatsoever. The most exciting thing to report is that the success rate is
running at 100% for those treated. Obviously there is much more to the story,
and if interested, then one should view the ACTC website and presentations for a
greater understanding
That up the share price just a little to closed at 0.0813 on 2.7 million shares. The three month avg. is 5.2 million shares.
Geron down 4 cents at $1.72 on 764,592 shares. The three month avg. volume is 712,632 shares. It's just a waiting game, good result in Dec 2012 we move up to $3 to $5, poor results 3 to 5 cents.
I love AAPL up $ 15.73 to close $610.75. It's going higher
Good luck in this rigged casino,
No comments:
Post a Comment